IRIS
SOZIO, Piera
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.254
EU - Europa 2.125
AS - Asia 1.184
SA - Sud America 97
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.670
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.225
CN - Cina 419
UA - Ucraina 380
SG - Singapore 369
IT - Italia 325
IE - Irlanda 316
GB - Regno Unito 303
SE - Svezia 239
FR - Francia 226
TR - Turchia 225
IN - India 130
DE - Germania 126
BR - Brasile 90
FI - Finlandia 82
RU - Federazione Russa 51
BE - Belgio 23
CA - Canada 21
CZ - Repubblica Ceca 18
HK - Hong Kong 12
IR - Iran 11
PL - Polonia 9
ES - Italia 8
LT - Lituania 7
MX - Messico 6
BD - Bangladesh 4
EU - Europa 4
GR - Grecia 3
PE - Perù 3
AL - Albania 2
AR - Argentina 2
HU - Ungheria 2
JP - Giappone 2
KE - Kenya 2
TN - Tunisia 2
UZ - Uzbekistan 2
VN - Vietnam 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
KR - Corea 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
ZA - Sudafrica 1
Totale 5.670
Salva come PNG Salva come JPEG
Città #
Chandler 415
Jacksonville 413
Dublin 312
Singapore 294
Southend 244
Princeton 138
Nanjing 124
Izmir 116
Chieti 98
Dearborn 94
Ashburn 93
Cambridge 69
Wilmington 66
Ann Arbor 59
Santa Clara 56
The Dalles 56
Altamura 55
Nanchang 44
Beijing 42
Boardman 35
Shenyang 31
New York 26
Tianjin 24
Washington 24
Brussels 23
Kunming 22
Kocaeli 20
Brno 18
Woodbridge 18
Los Angeles 17
Jiaxing 16
Grevenbroich 15
Hebei 15
Munich 14
Ningbo 14
Jinan 13
Leawood 13
Zhengzhou 13
Augusta 12
Hong Kong 12
Helsinki 11
Pescara 10
Ardabil 9
Toronto 9
Teramo 8
Auburn Hills 7
Guangzhou 7
London 7
Hangzhou 6
Kraków 6
Naples 6
San Mateo 6
Simi Valley 6
West Jordan 6
Falls Church 5
Lanzhou 5
Norwalk 5
Ottawa 5
Cepagatti 4
Changchun 4
Changsha 4
Frankfurt am Main 4
Hefei 4
Houston 4
Milan 4
Monmouth Junction 4
Montreal 4
Moscow 4
Orange 4
San Donato Milanese 4
Seattle 4
Sesena Nuevo 4
Silvi 4
Taizhou 4
Tappahannock 4
Boston 3
Boydton 3
Brooklyn 3
Buffalo 3
Chennai 3
Düsseldorf 3
Guarulhos 3
Lima 3
Nuremberg 3
Rio de Janeiro 3
Rovereto 3
Shanghai 3
São Paulo 3
Turku 3
Warsaw 3
Ankara 2
Bangalore 2
Cabo Frio 2
Chicago 2
Clifton 2
Curitiba 2
Dallas 2
Dhaka 2
Dong Ket 2
Haikou 2
Totale 3.440
Salva come PNG Salva come JPEG
Nome #
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 180
Synthesis of a novel cyclic prodrug of S -allyl-glutathione able to attenuate LPS-induced ROS production through the inhibition of MAPK pathways in U937 cells 136
A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation. 122
Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization 119
(R)-α-Lipoyl-glycyl-L-prolyl-L-glutamyl dimethyl ester codrug as a multifunctional agent with potential neuroprotective activities 117
Antiparkinson Prodrugs 114
Synthesis and preliminary pharmacological evaluation of 2,3,4,8,13a-hexahydro-1H-benzo(5,6)cyclohepta(1,2,3-ef)(3)benzazepine-6,7-diol derivatives as dopamine receptor ligands 112
Synthesis and evaluation of trans-2-amino-5(or 6)-chloro-6(or 5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 109
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 105
Characterization of alkanoyl-10-O-minocyclines in micellar dispersions as potential agents for treatment of human neurodegenerative disorders 104
L-Dopa Prodrugs: An Overview of Trends for Improving Parkinson's Disease Treatment 103
Ibuprofen and glutathione conjugate as a potential therapeutic agent for treating Alzheimer's disease 101
Gold nanoparticles as scaffolds for new antiparkinson prodrugs 99
Sintesi di trans-2-ammino-1-fenil-5-fluoro-6-idrossi (e 6-fluoro-5-idrossi)-2,3-diidro-1H-indeni quali potenziali ligandi per i recettori dopaminergici 98
CNS delivery of L-Dopa by a new Hybrid Glutathione-Methionine peptidomimetic prodrug 98
Synthesis and preliminary evaluation of L-dopa/benserazide conjugates as dual acting codrugs 97
Biodegradable microspheres loaded with an antiparkinson prodrug: an in vivo pharmacokinetic study 96
Design, synthesis and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs. 95
Synthesis and Study of L-Dopa-Glutathione Codrugs as New Anti-Parkinson Agents with Free Radical Scavenging Properties. 94
A new lipophilic molecular combination codrug-1 exerts neuroprotective activity in beta amyloid (1-40) infused Alzheimer’s disease rat model 94
synthesis and Activity of L-Dopa-Thiol antioxidant Co-drugs and New anti-PArkinson Agents with free Radical Scavenging Properties 92
Synthesis and preliminary pharmacological evaluation of trans-2-amino-5(6)-chloro-6(5)-hydroxy-1- phenyl-2,3-dihydro-1H-indenes as dopamine receptor ligands 91
Maleic- and Fumaric-diamides of (O,O-diacetyl)-L-Dopa-methylester as anti-Parkinson prodrugs in liposomal formulation 90
Evaluation of 2,3,4,8,13a hexahydro-1H-Benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 89
Design and synthesis of multifunctional drugs: a strategy to improve the treatment of Parkinson’s disease 89
Synthesis and biological evaluation of a novel pyroglutamil-modified TRH analogue 88
Ibuprofen and lipoic acid diamide as co-drugs with neuroprotective activity: pharmacological properties and effects in β-amyloid (1-40) infused Alzheimer’s disease rat model. 88
Detection of levodopa, dopamine and its metabolites in rat striatum dialysates following peripheral administration of L-DOPA prodrugs by mean of HPLC-EC 87
synthesis and biological evaluation as anti-Parkinson agent of an analogue of Glutathione-L-Dopa containing methionine in place of the cysteinil residue 87
Transition state isosteres of the gamma-glutamyl peptide bond hydrolysis: synthesis and characterization of the psi (CH2NH) pseudopeptide analogue of glutathione 87
Nuovi S-coniugati del glutatione ad attività inibitoria nei confronti delle GST umane 86
Evaluation of rat striatal L-Dopa and DA concentration after intraperitoneal administration of L- Dopa prodrugs in liposomal formulations 86
NOS-mediated morphological and molecular modifications in rats infused with Aβ (1-40), as a model of Alzheimer’s Disease, in response to a new lipophilic molecular combination codrug-1 86
Memantine-sulphur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 86
Codrugs Linking l-Dopa and Sulfur-Containing Antioxidants: New Pharmacological Tools against Parkinson’s Disease 85
Transdermal donepezil on the treatment of Alzheimer’s disease 85
Glycosyl and polyalcoholic prodrugs of lonidamine 84
Designing Prodrugs for the Treatment of Parkinson's Disease 84
New drug delivery strategies for improved Parkinson’s disease therapy 83
Ibuprofen and lipoic acid diamides as potential codrugs with neuroprotective activity 83
Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists 83
Synthesis and activity of novel glutathione analogues containing an urethane backbone linkage 78
Ibuprofen and lipoic Acid conjugate neuroprotective activity is mediated by ngb/akt intracellular signaling pathway in Alzheimer's disease rat model 77
Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate 77
L-Dopa- and dopamine- (R)-α-lipoic acid conjugates as multifunctional codrugs with antioxidant properties 75
Drug Delivery Strategies for Alzheimer's Disease Treatment 75
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 75
Dimeric L-dopa derivatives as potential prodrugs. 73
New L-Dopa codrugs as potential antiparkinson agents 73
Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug 72
Synthesis and biological evaluation of oligopeptides with antioxidant activity useful for treatment of neurodegenerative diseases 69
Effect of treatment with choline-contining Phospholipids on brain neurontransmitter transporters 68
The Investigation of Cytogenetic and Oxidative Effects of Diffractaic Acid on Human Lymphocyte Cultures 68
Haloperidol metabolite II prodrug: Asymmetric synthesis and biological evaluation on rat C6 glioma cells 68
Effect of choline-containing phospholipids on brain cholinergic transporters in the rat. 66
Dopaminergic system modulation, behavioral changes, and oxidative stress after neonatal administration of pyrethroids 65
Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: Development, characterization and interation with leuprolide 65
Evaluation of cytotoxic, oxidative stress and genotoxic responses of hydroxyapatite nanoparticles on human blood cells 65
Ibuprofen-Glutathione Conjugate as Anti-inflammatory and Anti-apoptotic Agent in Rat Brain Infused with β Amyloid (1-40) 64
Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain 63
Protective effects of cyclosativene on H2O 2-induced injury in cultured rat primary cerebral cortex cells 63
pPKC alpha.mediated effect on in vitro AB production in response to gamma secretase inhibitor LY411575in rat CTXTNA2 astrocytes. 62
Multifuctional L-Dopa Codrugs Containing Antioxidant Molecules 59
Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down - regulating Protein Kinase C ε – mediated Metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model 52
In vivo anti-apoptotic effect of compound 4 in rats infused with Abeta (1-40), as a model of Alzheimer's disease 47
In vivo anti-apoptotic effect of compound 4 in rats infused with Aβ (1-40), as a model of Alzheimer’s disease 46
Novel imidazoline compounds as partial or full agonists of D2-likedopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI 45
Lipid nanocarriers containing a levodopa prodrug with potential antiparkinsonian activity 44
Neuroprotective effects of farnesene against hydrogen peroxide-induced neurotoxicity in vitro 33
Totale 5.799
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.049
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 0 0 0 0 9
2020/2021483 72 3 71 4 50 83 9 7 20 80 67 17
2021/2022306 5 7 6 44 29 7 7 25 45 17 32 82
2022/20231.096 79 171 62 129 94 229 54 91 122 17 24 24
2023/2024493 35 23 43 12 37 152 125 4 5 5 1 51
2024/2025973 65 223 183 12 9 115 31 29 73 41 166 26
Totale 5.799